Fundraising FoxRekindle Therapeutics
Cambridge, US · Founded 2018 · Delaware corporation · 1 known investors
Find your way into Rekindle Therapeutics
Sign up to find every way you can get introduced to Rekindle Therapeutics
- Your email: who you already know at Rekindle Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Rekindle Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
Board
DB
EH
BG
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 round · 2018
▶$1.1MraisedNov 2018 · 4 investors · BiotechnologyRule 506(b)
▶$1.1MraisedNov 2018 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Detlev BiniszkiewiczExecutive Officer, Director
- Ed HurwitzDirector
- Bard GeesamanDirector
- Offering amount
- $6.5M
- Amount sold
- $1.1M
- Minimum investment
- $10K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Rekindle Therapeutics's investors?
- Rekindle Therapeutics's investors include MPM BioImpact.
- How much funding has Rekindle Therapeutics raised?
- Rekindle Therapeutics has disclosed $1.1M raised across 1 round.
- Where is Rekindle Therapeutics headquartered?
- Rekindle Therapeutics is headquartered in Cambridge, US.